Roxbury Financial LLC Buys Shares of 18,602 Oscar Health, Inc. $OSCR

Roxbury Financial LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 18,602 shares of the company’s stock, valued at approximately $213,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. OneDigital Investment Advisors LLC grew its stake in Oscar Health by 0.6% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after acquiring an additional 779 shares during the last quarter. Focus Partners Wealth lifted its holdings in shares of Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares in the last quarter. Equitable Holdings Inc. grew its position in shares of Oscar Health by 7.0% in the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after purchasing an additional 850 shares during the last quarter. Captrust Financial Advisors grew its position in shares of Oscar Health by 2.0% in the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after purchasing an additional 895 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC increased its stake in shares of Oscar Health by 5.6% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after purchasing an additional 938 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

OSCR has been the subject of several research reports. Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and lifted their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Barclays upgraded Oscar Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $30.00 to $35.00 in a report on Wednesday, June 10th. UBS Group raised their price target on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wells Fargo & Company set a $20.00 price target on Oscar Health and gave the stock an “equal weight” rating in a report on Thursday, June 4th. Finally, Robert W. Baird upped their price objective on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.78.

Insider Activity at Oscar Health

In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of Oscar Health stock in a transaction on Monday, April 6th. The shares were bought at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the purchase, the chief executive officer directly owned 10,196,876 shares in the company, valued at $121,546,761.92. This trade represents a 10.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Mario Schlosser sold 34,120 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares of the company’s stock, valued at $10,550,200.04. The trade was a 6.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock worth $4,283,140. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $28.52 on Tuesday. The company has a 50-day simple moving average of $21.89 and a 200-day simple moving average of $17.02. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market cap of $8.60 billion, a PE ratio of -48.35, a price-to-earnings-growth ratio of 1.99 and a beta of 2.37. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $29.81.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 earnings per share. The company’s quarterly revenue was up 52.6% compared to the same quarter last year. On average, equities analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.